Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

ImmunityBio

ImmunityBio
2014 FOUNDED
PRIVATE STATUS
Corporate LATEST DEAL TYPE
$30M LATEST DEAL AMOUNT
1 INVESTORS
Description

Developer of molecular-level cell-based treatments designed to treat cancer. The company develops immunology based treatments and drugs for the treatment of cancer and auto-immune diseases for the treatment of relapsed non-muscle invasive bladder cancer, enabling doctors to detect cancer in the early stage and evaluate the safety and initial efficacy of patients.

Formerly Known As
NantCell
Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 9920 Jeffersoon Boulvard
  • Culver City, CA 90232
  • United States

+1 (310) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore ImmunityBio’s full profile, request a free trial.

ImmunityBio Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Corporate 27-Dec-2018 $30M 00000 Completed Startup
2. Angel (individual) 14-Apr-2017 00.00 00000 Completed Startup
1. Undetermined 21-Jan-2016 $232M $232M Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

ImmunityBio Competitors (55)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
CytImmune Venture Capital-Backed Rockville, MD 000.00 0000000000 0 000.00
00000000 Venture Capital-Backed Tübingen, Germany 000 00000 00000000000 00000
000 000000000 Corporation Gainesville, FL 0 00.000 000000000000 00.000
00000 Venture Capital-Backed Boston, MA 0 0000 000
00000 000000000000 Formerly VC-backed New York, NY 00 000.00 000000000000 000.00
To view this company’s complete list of competitors, request access »

ImmunityBio Investments & Acquisitions (5)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000 0000000000 01-Aug-2017 000000000000000000 000 Biotechnology 0000000 0000-000000
00000000000 23-Mar-2017 000000000000000000 00.00 Biotechnology 0000000 0000-000000
0000000 01-Jan-2016 000000000000000000 Other Devices and Supplies
000000000 00000000 19-Oct-2015 000000000000000000 0000 Drug Discovery 0000000 0000-000000
Etubics 01-Oct-2015 Later Stage VC 0000 Other Devices and Supplies
To view this company’s complete investment and acquisition history, request access »

ImmunityBio Subsidiaries (3)

Company Name Industry Location Founded
Etubics Other Devices and Supplies Seattle, WA 2003
00000 0000000000 Biotechnology Miramar, FL 0000
00000000000 Biotechnology Louisville, CO 0000
To view this company’s complete subsidiary history, request access »

ImmunityBio Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Celgene Corporation Minority 000 0000 000000 0

ImmunityBio Executive Team (1)

Name Title Board
Seat
Contact
Info
Patrick Soon-Shiong Founder, Board Member & Chief Executive Officer

ImmunityBio Board Members (1)

Name Representing Role Since Contact
Info
Patrick Soon-Shiong ImmunityBio Founder, Board Member & Chief Executive Officer 000 0000